Transformation of MDS/MPN-RS-T to AML: Trisomy 13, Resistant Thrombocytosis and Transient Disease Control With Oral Busulfan Therapy

American Journal of Hematology - United States
doi 10.1002/ajh.24934
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Lenalidomide Therapy in Patients With Myelodysplastic Syndrome/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)

American Journal of Hematology
Hematology
2017English

Response to Erythropoiesis‐stimulating Agents in Patients With WHO‐defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis (MDS/MPN‐RS‐T)

British Journal of Haematology
Hematology
2020English

From MDS/AML to iPSC and Back Again

Science Translational Medicine
Medicine
2017English

Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Translocation T(1;3)(p36;p21) and Other Aberrations in a Case of AML Secondary to MDS

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2014English

Genetic Deletions in AML and MDS

Best Practice and Research in Clinical Haematology
OncologyClinical Biochemistry
2010English

Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS

Bone Marrow Transplantation
TransplantationHematology
2016English

Isolated Trisomy 13 Defines a Homogeneous AML Subgroup With High Frequency of Mutations in Spliceosome Genes and Poor Prognosis

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Cutaneous Leukemic Infiltrates Successfully Treated With Biomodulatory Therapy in a Rare Case of Therapy-Related High Risk MDS/AML

Frontiers in Pharmacology
Pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy